XML 51 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 8 - Segment Information (Tables)
6 Months Ended
Sep. 30, 2014
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
   

Three Months Ended September 30, 2014

 
   

Biological

Indicators

   

Instruments

   

Continuous

Monitoring

   

Total

 

Revenues

  $ 6,441     $ 9,065     $ 3,034     $ 18,540  
                                 

Gross profit

  $ 4,051     $ 5,455     $ 1,617     $ 11,123  

Selling expenses

    368       829       145       1,342  
    $ 3,683     $ 4,626     $ 1,472       9,781  

Reconciling items (1)

                            (5,038 )

Earnings before income taxes

                          $ 4,743  
                                 
   

Three Months Ended September 30, 2013

 
   

Biological

Indicators

   

Instruments

   

Continuous

Monitoring

   

Total

 

Revenues

  $ 6,010     $ 6,666     $ --     $ 12,676  
                                 

Gross profit

  $ 3,482     $ 4,118     $ --     $ 7,600  

Selling expenses

    556       863       --       1,419  
    $ 2,926     $ 3,255     $ --       6,181  

Reconciling items (1)

                            (3,243 )

Earnings before income taxes

                          $ 2,938  
   

Six Months Ended September 30, 2014

 
   

Biological

Indicators

   

Instruments

   

Continuous

Monitoring

   

Total

 

Revenues

  $ 12,858     $ 16,750     $ 5,332     $ 34,940  
                                 

Gross profit

  $ 7,835     $ 10,382     $ 2,611     $ 20,828  

Selling expenses

    772       1,821       812       3,405  
    $ 7,063     $ 8,561     $ 1,799       17,423  

Reconciling items (1)

                            (9,787 )

Earnings before income taxes

                          $ 7,636  
   

Six Months Ended September 30, 2013

 
   

Biological

Indicators

   

Instruments

   

Continuous

Monitoring

   

Total

 

Revenues

  $ 10,864     $ 13,030     $ --     $ 23,894  
                                 

Gross profit

  $ 6,043     $ 8,354     $ --     $ 14,397  

Selling expenses

    946       1,556       --       2,502  
    $ 5,097     $ 6,798     $ --       11,895  

Reconciling items (1)

                            (5,942 )

Earnings before income taxes

                          $ 5,953  
Reconciliation of Assets from Segment to Consolidated [Table Text Block]
   

September 30, 2014

   

March 31, 2014

 

Total assets

               

Biological Indicators

  $ 26,582     $ 22,771  

Instruments

    46,023       36,797  

Continuous Monitoring

    31,182       28,578  

Corporate and administrative

    8,313       9,383  
    $ 112,100     $ 97,529  
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
   

Three Months Ended

September 30,

   

Six Months Ended

September 30,

 
   

2014

   

2013

   

2014

   

2013

 

Net revenues from unaffiliated customers:

                               

United States

  $ 9,698     $ 7,794     $ 18,189     $ 13,824  

Foreign

    8,842       4,882       16,751       10,070  
    $ 18,540     $ 12,676     $ 34,940     $ 23,894